Klaviyo ($KVYO) Beats Earnings, Expects Q1 Revenue $201-$203M, FY 2024 Revenue $889-$897M
Klaviyo ($KVYO) reported strong Q4 earnings with EPS of $0.09, beating Street estimates of $0.08. Revenue reached $201.6M, surpassing the consensus of $196.2M. The company expects Q1 revenue of $201-$203M and FY 2024 revenue of $889-$897M, both above analyst expectations. Total customers increased by 20% year over year to 143,000, with customers generating $50K+ ARR growing by 80% to 1,958. Gross margin stood at 74%. Q1 revenue is anticipated to be at least $201M, a 29% increase year over year.
Sources
Bio Stocks™
$TGTX Q4 and FY'23 BRIUMVI net revenue ~40M and $89M. Year-end ash position of $217.5M. FY'24 Target BRIUMVI Guidance: BRIUMVI U.S. net product revenue target of $220M to $260M
HedgeMind $KVYO Q4 earnings results: Revs up 39% y/y to $201.6M - Gross margin was 74% Total customers up 20% y/y to 143,000 - Customers w/ $50K+ ARR up 80% y/y to 1,958 Expect Q1 revs to be min $201M, up 29% y/y https://t.co/9d6u5ggSOO https://t.co/m3Oc64cios https://t.co/Y8TFM75Cyi
Mukund Mohan $KVYO Beat and raise Posts Q4 EPS $0.09, vs. Street Est of $0.08 Posts Q4 Revenue $201.6M, vs. Street Est of $196.2M Guides For Q1 Revenue of $201-$203 Million, vs Consensus of $200 Million; FY 2024 Seen at $889-$897 Million, vs Consensus of $888 Million